Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Combogesic® (acetaminophen/ibuprofen) – New drug approval
March 1, 2023, - The FDA approved AFT Pharmaceuticals’ Combogesic (acetaminophen/ibuprofen), for the short-term management of mild to moderate acute pain.
